Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).

Blumenschein, G R; Smit, E F; Planchard, D; Kim, D-W; Cadranel, J; De Pas, T; Dunphy, F; Udud, K; Ahn, M-J; Hanna, N H; Kim, J-H; Mazieres, J; Kim, S-W; Baas, P; Rappold, E; Redhu, S; Puski, A; Wu, F S; Jänne, P A.

Ann Oncol ; 26(5): 894-901, 2015 May.

Artículo en Inglés | MEDLINE | ID: mdl-25722381

2.

Targeting BAP1: a new paradigm for mesothelioma.

Schunselaar, L M; Zwart, W; Baas, P.

Lung Cancer ; 109: 145-146, 2017 07.

Artículo en Inglés | MEDLINE | ID: mdl-28342657

3.

Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.

Kruijtzer, C M F; Schellens, J H M; Mezger, J; Scheulen, M E; Keilholz, U; Beijnen, J H; Rosing, H; Mathôt, R A A; Marcus, S; van Tinteren, H; Baas, P.

J Clin Oncol ; 20(23): 4508-16, 2002 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-12454106

4.

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.

Sahmoud, T; Postmus, P E; van Pottelsberghe, C; Mattson, K; Tammilehto, L; Splinter, T A; Planting, A S; Sutedja, T; van Pawel, J; van Zandwijk, N; Baas, P; Roozendaal, K J; Schrijver, M; Kirkpatrick, A; Van Glabbeke, M; Ardizzoni, A; Giaccone, G.

Eur J Cancer ; 33(13): 2211-5, 1997 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-9470808

5.

Use of sheet color filters for video-endoscopic observation during intraluminal photodynamic therapy.

Marijnissen, J P; Boot, H; Baas, P.

Lasers Surg Med ; 18(1): 96-9, 1996.

Artículo en Inglés | MEDLINE | ID: mdl-8850472

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).

Targeting BAP1: a new paradigm for mesothelioma.

Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.

Use of sheet color filters for video-endoscopic observation during intraluminal photodynamic therapy.

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).

Targeting BAP1: a new paradigm for mesothelioma.

Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.

Use of sheet color filters for video-endoscopic observation during intraluminal photodynamic therapy.

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).